US FDA’s Marks Criticizes UK For ‘Rushing’ Adverse Event Announcement On COVID Vaccine

The allergic reactions ‘just occurred yesterday and they haven’t been fully investigated,’ CBER Director Marks says.

popcorn
Is the crowded theater on fire, or is the popcorn just burnt? • Source: Shutterstock

Peter Marks, director of the US Food and Drug Administration’s Center for Biologics Evaluation and Research, criticized the UK’s quick release of a safety notice on adverse events about Pfizer/BioNTech’s COVID vaccine, saying there was too little context for public understanding.

After reports of two frontline national health service (NHS) staff experiencing allergic reactions related to the vaccine, named BNT162b2, the...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Drug Safety

More from Pink Sheet